Regeneus Ltd's (ASX:RGS) Leo Lee speaks to Proactive's Andrew Scott while at the virtual ASX Small and Mid-Cap Conference 2020. They're an Australian biotech looking to improve the quality of life for patients suffering from pain. It develops regenerative medicine products that interrupt the inflammatory cascade that leads to pain.
viewRegeneus Ltd
Regeneus Ltd with Proactive at the ASX Small and Mid-Cap Conference 2020
Quick facts: Regeneus Ltd
Price: 0.12 AUD
ASX:RGS
Market: ASX
Market Cap: $36.03 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive
Oncimmune continues building momentum with partnerships
Most read
Industry & services
New space ETF on the horizon lifts shares in Virgin Galactic, Maxar and SRAC
6 days, 17 hours ago
Finance
Are mining stocks on a new bull run? One influential investment bank thinks so
6 days, 18 hours ago
Mining
Pembridge Resources announces appointments of new president and interim CFO...
6 days, 23 hours ago
